Get the Stockscreener App
6.05
16.12%
0.84
After Hours:
6.20
0.15
+2.48%
Certara Inc stock is traded at $6.05, with a volume of 7.11M.
It is up +16.12% in the last 24 hours and up +35.04% over the past month.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.
See More
Previous Close:
$5.21
Open:
$5.24
24h Volume:
7.11M
Relative Volume:
1.80
Market Cap:
$941.17M
Revenue:
$419.75M
Net Income/Loss:
$-15.10M
P/E Ratio:
-63.48
EPS:
-0.0953
Net Cash Flow:
$63.10M
1W Performance:
+16.80%
1M Performance:
+35.04%
6M Performance:
-30.14%
1Y Performance:
-43.77%
1-Day Range:
$5.24
$6.165
1-Week Range:
$4.965
$6.165
52-Week Range:
$4.45
$13.88
Certara Inc Stock (CERT) Company Profile
Name
Certara Inc
Sector
Industry
Phone
(415) 237-8272
Address
4 RADNOR CORPORATE CENTER, SUITE 350, RADNOR
Compare CERT vs VEEV, BTSG, TEM, HQY, HNGE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CERT
Certara Inc
|
6.05 | 810.49M | 419.75M | -15.10M | 63.10M | -0.0953 |
VEEV
Veeva Systems Inc
|
163.38 | 26.34B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
64.14 | 12.58B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
50.56 | 9.39B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
85.66 | 7.27B | 1.34B | 230.70M | 440.96M | 2.6695 |
HNGE
Hinge Health Inc
|
67.81 | 5.29B | 646.34M | -512.40M | 202.76M | -6.6871 |
Certara Inc Stock (CERT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-26 | Downgrade | Barclays | Overweight → Equal Weight |
| Feb-27-26 | Downgrade | Craig Hallum | Buy → Hold |
| Jan-06-26 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Nov-21-25 | Initiated | Rothschild & Co Redburn | Buy |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Sep-29-25 | Initiated | Craig Hallum | Buy |
| Jul-03-25 | Resumed | Morgan Stanley | Equal-Weight |
| May-08-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Feb-27-25 | Initiated | TD Cowen | Buy |
| Sep-27-24 | Upgrade | UBS | Neutral → Buy |
| Apr-10-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-04-24 | Initiated | JMP Securities | Mkt Perform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-07-23 | Initiated | UBS | Neutral |
| Dec-05-23 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Aug-22-23 | Downgrade | Jefferies | Buy → Hold |
| Aug-10-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Apr-03-23 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-14-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Sep-08-22 | Initiated | Berenberg | Buy |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jul-01-22 | Initiated | Piper Sandler | Overweight |
| Jan-11-22 | Upgrade | Jefferies | Hold → Buy |
| Aug-05-21 | Resumed | Credit Suisse | Neutral |
| Jul-23-21 | Initiated | Robert W. Baird | Outperform |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jan-06-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jan-05-21 | Initiated | BofA Securities | Buy |
| Jan-05-21 | Initiated | Credit Suisse | Neutral |
| Jan-05-21 | Initiated | Jefferies | Hold |
| Jan-05-21 | Initiated | William Blair | Outperform |
View All
Certara Inc Stock (CERT) Latest News
CERT Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Certara outlines AI push, cost cuts and new growth engines at Jefferies conference - MSN
Certara Inc. (CERT) Q1 2026 Earnings: EPS Miss Weighs on Shares as Biosimulation Demand Remains SteadySpecial Dividend Alert - newsline.com
CERT Q1 2026 Earnings: EPS Misses Estimates, Stock DeclinesMid-Term Outlook - newsline.com
Certara Q1 2026 Earnings: EPS Misses Estimates, Stock Slips as Revenue Details Remain UnclearDividend Increase Stocks - newsline.com
CERT Investors Have Opportunity to Join Certara, Inc. Fraud Inve - GuruFocus
CERT Investors Have Opportunity to Join Certara, Inc. Fraud Investigation with the Schall Law Firm - Morningstar
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc.CERT - FinancialContent
Certara Company Profile & Introduction - Moomoo
Price-Driven Insight from (CERT) for Rule-Based Strategy - Stock Traders Daily
Certara Outlines AI Push, Cost Cuts and New Growth Engines at Jefferies Conference - MarketBeat
Certara Inc stock (US1567671046): Shares under pressure after investigation headlines - AD HOC NEWS
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Certara, Inc. (CERT) And Encourages Shareholders to Reach Out - ACCESS Newswire
2026-06-05 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Certara, Inc. (CERT) And Encourages Shareholders to Reach Out | NDAQ:CERT | Press Release - Stockhouse
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
How Certara (CERT) Investors Can Read The Quiet Shift In The Valuation Story - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Certara, Inc. (CERT) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
2026-06-04 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Certara, Inc. (CERT) and Encourages Shareholders to Learn More About the Investigation | NDAQ:CERT | Press Release - Stockhouse
Barclays downgrades Certara stock rating on turnaround concerns - Investing.com
CERT Technical Analysis & Stock Price Forecast - Intellectia AI
Certara, Inc. Stock Hits Day Low of $5.55 Amid Price Pressure - MarketsMojo
Certara, Inc. (CERT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Certara Inc at Jefferies Global Healthcare Conference in New York Transcript - GuruFocus
Certara, Inc. (CERT) Investigation: Bronstein, Gewirtz & Grossman - The National Law Review
Do Options Traders Know Something About Certara Stock We Don't? - MSN
Certara (CERT) CHRO nets shares from RSU vesting and tax withholding - Stock Titan
Certara (CERT) SVP Daniel Corcoran exercises RSUs; 12,103 shares withheld for taxes - Stock Titan
Certara, Inc. (CERT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages Certara, Inc. (CERT - The National Law Review
Is Now An Opportune Moment To Examine Certara, Inc. (NASDAQ:CERT)? - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Is Investigating Certara, Inc. (CERT) And Encourages Investors to Connect - ACCESS Newswire
Certara Inc stock (US1567671046): Q1 2026 services slowdown and investor lawsuit probe keep focus on - AD HOC NEWS
Certara (CERT) shares slide after weak full-year guidance overshadows revenue beat - MSN
Bronstein, Gewirtz & Grossman, LLC Encourages Certara, Inc. (CERT) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Certara, Inc. (CERT) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Certara Inc. (CERT) Edges Higher as Shares Hold Above Key SupportKey Reversal Day - newsline.com
Certara Inc stock (US1567671046): shares slip after Q1 2026 revenue mix and legal probe headline - AD HOC NEWS
(CERT) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Certara says AI investments will drive long-term growth – but traders are focused on one warning - MSN
Certara, Inc. (CERT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Certara, Inc. (CERT) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages Certara, Inc. (CERT) Investors to Inquire about Securities Investigation - ACCESS Newswire
Certara Q1 2026 Earnings: EPS Misses Estimates but Stock Gains 1.35%Final Results - The League of Women Voters of Texas
CERT Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
CERT Investors Have Opportunity to Join Certara, Inc. Fraud Investigation with the Schall Law Firm - GlobeNewswire Inc.
EDGAR Filing Documents for 0001827090-23-000010 - SEC.gov
Certara, Inc. (CERT) Q1 earnings miss estimates - MSN
Certara Inc. (CERT) Q1 2026 Earnings: EPS Misses Estimates as Stock Rises on Solid Operational ProgressEarnings Beat Alert - newsline.com
Certara shares drop 19% after Q1 revenue decline and management inconsistency concerns. - Pluang
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Certara, Inc. (CERT) And Encourages Investors to Reach Out - ACCESS Newswire
Certara Inc Stock (CERT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Certara Inc Stock (CERT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Corcoran Daniel | SVP and General Counsel |
Jun 01 '26 |
Option Exercise |
0.00 |
22,830 |
0 |
39,939 |
| Collins Cynthia | Director |
May 14 '26 |
Option Exercise |
0.00 |
15,757 |
0 |
51,846 |
| Reynders John V W | Chief Financial Officer |
May 14 '26 |
Option Exercise |
0.00 |
15,757 |
0 |
26,466 |
| BROSHY ERAN | Chairman |
May 14 '26 |
Option Exercise |
0.00 |
15,757 |
0 |
50,708 |
| Bedi Arjun | Director |
May 14 '26 |
Option Exercise |
0.00 |
5,547 |
0 |
5,547 |
| CASHMAN JAMES E III | Chairman |
May 14 '26 |
Option Exercise |
0.00 |
15,757 |
0 |
484,197 |
| Killefer Nancy | Director |
May 14 '26 |
Option Exercise |
0.00 |
15,757 |
0 |
51,846 |
| Crane Rosemary A | Director |
May 14 '26 |
Option Exercise |
0.00 |
15,757 |
0 |
45,672 |
| WALSH MATTHEW M | Director |
May 14 '26 |
Option Exercise |
0.00 |
15,757 |
0 |
213,316 |
| Resnick Jon Matthew | Chief Executive Officer |
May 11 '26 |
Option Exercise |
0.00 |
59,766 |
0 |
59,766 |
2.22%
0.92%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):